The American College of Rheumatology (ACR) honored 43 researchers and thought leaders with its Master of the ACR designation, Awards of Distinction, and Distinguished Fellow Award for their contributions to the field of rheumatology. The recognitions are given annually to members who exhibit outstanding achievements in scholarly achiev...
A digital health coaching program improved RA patients' well-being, decreased symptoms, and reduced flare frequency. The program showed significant increases in physical activity, sleep hours, and medication adherence.
Research finds that RA patients who meet certain factors, including younger age and low CRP levels, are more likely to successfully taper their biologic drugs. Patients without concomitant steroid use also tend to have better outcomes.
A study found that patients with spine osteoarthritis and those under 65 are more likely to use opioids for pain management. The study also showed a significant association between opioid use and greater depressive symptoms, as well as higher levels of pain.
Research found associations between opioids and SSRIs with increased osteoporotic fracture risk in RA patients, particularly with long-term use. Patients who developed fractures had higher disease activity, longer disease duration, and more comorbidity at baseline compared to those who did not experience fractures.
The new dashboard provides actionable data to practices, allowing them to track quality improvement and financially reward their efforts in the MIPS program. Data from 548,990 patients reported by 491 clinicians and 109 practices showed varying performance on quality measures.
A new mobile app-based system, Smart System of Disease Management (SSDM), has been developed to improve care management for chronic illness patients. The system includes online consultation via a mobile app, which reduces costs and delays for arthritis patients by allowing them to access medical services remotely.
Researchers developed a new tool to analyze cellular and molecular profiles of synovial tissue and peripheral blood, which may help unlock clues about rheumatoid arthritis. The study found that robust cell yield from synovial tissue enables mass and flow cytometric data.
The EULAR and ACR presented draft new classification criteria for systemic lupus erythematosus (SLE) at the 2017 ACR/ARHP Annual Meeting. The updated criteria aim to improve patient identification, trial comparisons, and early disease detection, with a global collaboration involving over 150 investigators and data from 2,200 patients.
A new online education tool has been developed to improve accessibility and disease self-management for teens with juvenile idiopathic arthritis. The tool, which includes monthly calls with health coaches, improved health-related quality of life for participating teens compared to those who received standard disease education only.
Research found that lupus patients on Medicaid have lower HCQ therapy adherence in areas with high African-American populations, few hospitals, and Health Professional Shortage Areas. This association remained after controlling for individual-level characteristics like poverty and education.
Research findings from the ACR/ARHP Annual Meeting reveal that obesity is independently associated with worse patient-reported outcomes in women with systemic lupus erythematosus, including increased disease activity and depressive symptoms. Obesity was linked to higher levels of pain and fatigue as well.
A study found that positive sacroiliac MRI scans can be common in healthy individuals and frequent runners, suggesting the need for additional diagnostic measures. The research emphasizes the importance of considering these results in context to avoid misdiagnosis of axial spondyloarthritis.
A study of 1,678 RA patients found no increased risk of second malignancy among those treated with biologics after a primary cancer diagnosis. Hazard ratios showed a slightly higher mortality rate among RA patients who received biologics before their cancer diagnosis.
Research suggests that obesity is prevalent among axSpa patients, associated with increased disease activity, physical function impairment, and poorer quality of life. The study found that nearly two-thirds of the patient cohort were overweight or obese, highlighting the need for weight management strategies in treatment plans.
Researchers found that low-energy shock-wave therapy significantly reduced digital ulcers in scleroderma patients by stimulating growth factors and forming new blood vessels. The treatment also showed no serious adverse events during the study, making it a promising approach for managing refractory digital ulcers.
The new American College of Rheumatology/National Psoriasis Foundation treatment guideline provides pharmacologic and non-pharmacologic recommendations for treating adult patients with active psoriatic arthritis. The guideline development team used the GRADE methodology to evaluate evidence and create therapy options.
A new guideline aims to reduce joint infection risks from total hip and knee replacements by managing anti-rheumatic medications during perioperative process. The guideline provides recommendations for withholding certain medications, such as biologics and immunosuppressants, to minimize the risk of infection.
The ACR's updated clinical guideline provides recommendations for assessing fracture risk and treatment for adults and special patient populations. For all age groups, the panel strongly recommends optimizing calcium and vitamin D intake and implementing lifestyle modifications to prevent glucocorticoid-induced osteoporosis.
A 10-year precision trial involving 24,081 patients in 13 countries investigated the cardiovascular safety of widely used nonsteroidal anti-inflammatory drugs and COX-2-specific inhibitors. The trial found that celecoxib shares similar cardiovascular toxicity with rofecoxib, leading to increased nuance in analgesic recommendations for ...
Research findings suggest that gut microbiomes of patients with antiphospholipid syndrome show higher levels of phospholipid-producing bacteria, pointing to microbes as a trigger for the disease. The study identified Slackia bacteria as a promising candidate, which can produce phospholipids including cardiolipin.
New research findings suggest that men and women have different post-surgical outcomes after total hip arthroplasty. Women who had improved functional recovery showed more abductor strength improvement and better gait function during walking. Tailoring rehabilitation to each sex may help patients achieve better outcomes.
Researchers found that patients treated with rituximab as their first biologic had a lower mortality risk compared to those treated with TNFi. The study included 353 patients with RA-ILD and analyzed five-year mortality rates, with RTX-treated patients showing numerically lower but not statistically significant risks.
Research finds elevated myocardial inflammation in RA patients, with treatment showing potential to improve inflammation levels. Studies use advanced imaging techniques to detect and quantify heart inflammation, suggesting a link between joint and heart inflammation.
Researchers found a significant interaction between TNF-inhibitors and NSAIDs, with patients experiencing a 70% reduction in radiographic progression when used together. The study suggests that combining these therapies may be especially helpful for patients at higher risk of disease progression.
Research shows that many patients with RA, spondyloarthritis, and other inflammatory joint diseases are not receiving adequate CVD-preventive medications, despite being at high risk. Only half of those who start treatment achieve their goals, highlighting a significant need for improvement in CVD prevention.
Researchers identified three gene expression signatures that can help rheumatologists predict which patients are more likely to respond to certain therapies. The findings could lead to higher response rates and reduced likelihood of ineffective treatment, ultimately improving patient care.
A study of 564 patients found that women with long-term axial spondyloarthropathy are at higher risk for extra-articular manifestations, including uveitis, which is significantly more prevalent in women (46.7%) and those in late disease stages. IBD prevalence was also higher in women (16.5%), particularly those with elevated CRP levels.
Research suggests that RA patients who receive combined care from primary-care physicians and rheumatologists are more likely to be screened for hyperlipidemia. This study found that 47% of patients seeing both a PCP and rheumatologist were screened, compared to 42% of those seeing only a PCP.
A study of 9,362 surgeries on 5,544 RA patients found that continuing DMARDs prior to surgery does not increase post-operative infection risk. Researchers recommend considering medication continuation during the perioperative period to maintain better control over RA and reduce complications.
The U.S. adult rheumatology workforce is projected to decline by 31% by 2030 due to an aging workforce and insufficient graduate medical education funding. To address this gap, researchers suggest creating financial incentives for medical students and residents to pursue rheumatology training.
A retrospective cohort study found that chronic kidney disease patients who achieve target urate levels show improvement in kidney function. The study suggests that urate-lowering therapy may help stabilize or improve kidney function in patients with significantly elevated serum uric acid and moderate kidney failure.
Researchers found that people with RA have double the risk of CV events as those in the general population, rates similar to those with type-2 diabetes. Chronic inflammation in RA contributes independently to cardiovascular risks for these patients.
Researchers found distinct monocyte gene expression signatures in RA patients with different responses to anti-TNF therapy, potentially leading to personalized treatment approaches.
New research from the American College of Rheumatology finds that most people with knee osteoarthritis (OA) meet the minimum physical function level necessary to walk at least 6,000 steps a day. This suggests that many individuals with OA can adopt physically active lifestyles and achieve significant health benefits.
Quality of care varies significantly among rheumatology practices, with the largest gaps seen in osteoporosis and gout care, and some practices consistently performing well across measures. The study highlights the need for improvement in preventive care and counseling, and RISE provides a tool for guiding quality-improvement efforts.
New research finds that African-Americans, Asians, and those with a high school education or less experience significant delays in receiving lupus diagnosis and treatment. The study highlights the need for targeted solutions to address these disparities in access to specialty care.
Research finds that tumor necrosis factor inhibitors used to treat juvenile idiopathic arthritis do not increase the risk of malignancy. The study, which analyzed data from over 27,000 children with JIA, concluded that TNFi are not associated with a significantly increased risk of incident malignancy.
Research found no association between allopurinol use and increased risk of chronic kidney disease (CKD) Stage 3 or higher in gout patients with normal kidney function. Allopurinol may be beneficial for preventing renal decline, suggesting its safe use in managing gout symptoms.
Researchers found that statin initiation was associated with a 33% reduction in all-cause mortality among AS and PsA patients. The study suggests that statins' dual benefits of lowering lipids and reducing inflammation may be the reason for this significant benefit.
A new Wnt inhibitor drug has shown significant improvements in knee OA pain, joint function, and even slowed or reversed cartilage loss. The study found that the drug improved outcomes for 76% of patients in the high-dose group compared to 36% on placebo.
The American College of Rheumatology has received a $335,000 grant from the Office of Minority Health to develop an expert-informed program model that improves health outcomes for people with lupus in rural and underserved areas. The program aims to increase awareness and access to care for patients living with lupus.